NCT03025074Recruiting
Blood Collection Biorepository for Liver Disease Research
Virology, Immunology and Mechanisms of Liver Disease in Patients With Hepatitis C and Other Liver Diseases
Source: ClinicalTrials.gov · Last updated 8 Oct 2026
Brief summary (registry, in English)
The purpose of establishing a biorepository is to provide high quality specimens (serum, plasma, buffy coat and liver tissue) for future researchers who are studying the effects that fatty liver and viral diseases have on the liver.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 16 Jan 2017
- Start date
- 1 Jul 2013
- Primary completion date
- 31 Dec 2099
- Lead sponsor
- State University of New York at Buffalo
- NCT number
- NCT03025074
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 1 Jul 2013 to the primary completion date, 31 Dec 2099
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Vulnerable populations such as adults unable to consent, infants, pregnant women or prisoners will not be considered for this research study.
Who the study is looking for
- This protocol is to establish a biobank of blood samples from individuals with or without liver diseases including viral hepatitis, liver cancer, NASH, and negative control samples.
- Children and teenagers will be special populations considered in this protocol.
Age in the registry: 7 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University at Buffalo, Buffalo General Medical Center Coordinator of this site? Confirm its status | Buffalo | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.